223-top cited artilces
No.TypeYearCategoryCountryCitationJournalTypePMIDArticle
1Non-CNA2013epidemiologyU.K2604NatureJournal Article23563266Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI. The global distribution and burden of dengue. Nature. 2013 Apr 25;496(7446):504-7. doi: 10.1038/nature12060. Epub 2013 Apr 7.
2Non-CNA1998virologyColorado796Clin Microbiol RevJournal Article9665979Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998 Jul;11(3):480-96.
3Non-CNA2011diagnosis796Klin Lab DiagnEnglish Abstract21786619Nafeev AA, Savel'eva NV, Sibaeva ?I. Laboratory tests in the diagnosis of feral herd infections. Klin Lab Diagn. 2011 May;(5):52-3.
4Non-CNA2016disease outbreaksFrench Polynesia766LancetJournal Article269484332016
5Non-CNA2010diagnosisCuba590Nat Rev MicrobiolJournal Article210796552010
6CNA2000bloodMaryland562J Infect DisJournal Article10608744Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000 Jan;181(1):2-9. doi: 10.1086/315215.
7Non-CNA1992isolation & purificationColorado546J Clin MicrobiolJournal Article1372617Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol. 1992 Mar;30(3):545-51. doi: 10.1128/JCM.30.3.545-551.1992.
8Non-CNA2007geneticsMaryland520ScienceJournal Article175103242007
9CNA2007dengueSouth Korea510LancetJournal Article17993365Halstead SB. Dengue. Lancet. 2007 Nov 10;370(9599):1644-52. doi: 10.1016/S0140-6736(07)61687-0.
10CNA2011microbiologyAustralia507NatureEvaluation Study21866160Hoffmann AA, Montgomery BL, Popovici J, Iturbe-Ormaetxe I, Johnson PH, Muzzi F, Greenfield M, Durkan M, Leong YS, Dong Y, Cook H, Axford J, Callahan AG, Kenny N, Omodei C, McGraw EA, Ryan PA, Ritchie SA, Turelli M, O'Neill SL. Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission. Nature. 2011 Aug 24;476(7361):454-7. doi: 10.1038/nature10356.
11CNA2011microbiology507NatureComment21866151Rasgon JL. Dengue fever: Mosquitoes attacked from within. Nature. 2011 Aug 24;476(7361):407-8. doi: 10.1038/476407a.
12Non-CNA1988etiologyNew York482ScienceJournal Article3277268Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science. 1988 Jan 29;239(4839):476-81. doi: 10.1126/science.3277268.
13CNA2004transmissionAustralia456Nat MedJournal Article15577938Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med. 2004 Dec;10(12 Suppl):S98-109. doi: 10.1038/nm1144.
14Non-CNA2012microbiologyCalifornia433J Theor BiolJournal Article22192469Schraiber JG, Kaczmarczyk AN, Kwok R, Park M, Silverstein R, Rutaganira FU, Aggarwal T, Schwemmer MA, Hom CL, Grosberg RK, Schreiber SJ. Constraints on the use of lifespan-shortening Wolbachia to control dengue fever. J Theor Biol. 2012 Mar 21;297:26-32. doi: 10.1016/j.jtbi.2011.12.006. Epub 2011 Dec 16
15Non-CNA2011microbiologyAustralia433NatureJournal Article21866159Walker T, Johnson PH, Moreira LA, Iturbe-Ormaetxe I, Frentiu FD, McMeniman CJ, Leong YS, Dong Y, Axford J, Kriesner P, Lloyd AL, Ritchie SA, O'Neill SL, Hoffmann AA. The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations. Nature. 2011 Aug 24;476(7361):450-3. doi: 10.1038/nature10355.
16Non-CNA2012epidemiologyU.K432PLoS Negl Trop DisJournal Article22880140Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, Moyes CL, Farlow AW, Scott TW, Hay SI. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012;6(8):e1760. doi: 10.1371/journal.pntd.0001760. Epub 2012 Aug 7.
17Non-CNA2016antibody-dependent enhancementU.K381Nat ImmunolJournal Article273390992016
18Non-CNA2014complicationsFrench Polynesia374Euro SurveillCase Reports24626205Oehler E, Watrin L, Larre P, Leparc-Goffart I, Lastere S, Valour F, Baudouin L, Mallet H, Musso D, Ghawche F. Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013. Euro Surveill. 2014 Mar 6;19(9):20720. doi: 10.2807/1560-7917.es2014.19.9.20720.
19Non-CNA2008physiologyMaryland354PLoS PathogJournal Article18604274Xi Z, Ramirez JL, Dimopoulos G. The Aedes aegypti toll pathway controls dengue virus infection. PLoS Pathog. 2008 Jul 4;4(7):e1000098. doi: 10.1371/journal.ppat.1000098.
20Non-CNA2010immunologyU.K349ScienceJournal Article204481832010
21Non-CNA2014prevention & controlPhilippines337LancetClinical Trial, Phase III25018116Capeding MR, Tran NH, Hadinegoro SR, Ismail HI, Chotpitayasunondh T, Chua MN, Luong CQ, Rusmil K, Wirawan DN, Nallusamy R, Pitisuttithum P, Thisyakorn U, Yoon IK, van der Vliet D, Langevin E, Laot T, Hutagalung Y, Frago C, Boaz M, Wartel TA, Tornieporth NG, Saville M, Bouckenooghe A. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet. 2014 Oct 11;384(9951):1358-65. doi: 10.1016/S0140-6736(14)61060-6. Epub 2014 Jul 10.
22Non-CNA2003physiologyMaryland333J Exp MedJournal Article12682107Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke J, Sun W, Eller MA, Pattanapanyasat K, Sarasombath S, Birx DL, Steinman RM, Schlesinger S, Marovich MA. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med. 2003 Apr 7;197(7):823-9. doi: 10.1084/jem.20021840.
23Non-CNA2003physiologyU.K332Nat MedJournal Article12808447Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, Chairunsri A, Sawasdivorn S, Duangchinda T, Dong T, Rowland-Jones S, Yenchitsomanus PT, McMichael A, Malasit P, Screaton G. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med. 2003 Jul;9(7):921-7. doi: 10.1038/nm887.
24Non-CNA2009microbiologyAustralia330ScienceJournal Article19119237McMeniman CJ, Lane RV, Cass BN, Fong AW, Sidhu M, Wang YF, O'Neill SL. Stable introduction of a life-shortening Wolbachia infection into the mosquito Aedes aegypti. Science. 2009 Jan 2;323(5910):141-4. doi: 10.1126/science.1165326.
25Non-CNA2017isolation & purificationMassachusetts330ScienceJournal Article28408723Gootenberg JS, Abudayyeh OO, Lee JW, Essletzbichler P, Dy AJ, Joung J, Verdine V, Donghia N, Daringer NM, Freije CA, Myhrvold C, Bhattacharyya RP, Livny J, Regev A, Koonin EV, Hung DT, Sabeti PC, Collins JJ, Zhang F. Nucleic acid detection with CRISPR-Cas13a/C2c2. Science. 2017 Apr 28;356(6336):438-442. doi: 10.1126/science.aam9321. Epub 2017 Apr 13
26Non-CNA2015prevention & controlIndonesia328N Engl J MedClinical Trial, Phase III26214039Hadinegoro SR, Arredondo-García JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, Muhammad Ismail HI, Reynales H, Limkittikul K, Rivera-Medina DM, Tran HN, Bouckenooghe A, Chansinghakul D, Cortés M, Fanouillere K, Forrat R, Frago C, Gailhardou S, Jackson N, Noriega F, Plennevaux E, Wartel TA, Zambrano B, Saville M. Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. N Engl J Med. 2015 Sep 24;373(13):1195-206. doi: 10.1056/NEJMoa1506223. Epub 2015 Jul 27.
27CNA2004growth & development312Med Vet EntomolJournal Article15347388Gratz NG. Critical review of the vector status of Aedes albopictus. Med Vet Entomol. 2004 Sep;18(3):215-27. doi: 10.1111/j.0269-283X.2004.00513.x.
28CNA2012growth & developmentCzech Republic312Euro SurveillJournal Article23137465?ebesta O, Rudolf I, Betášová L, Peško J, Hubálek Z. An invasive mosquito species Aedes albopictus found in the Czech Republic, 2012. Euro Surveill. 2012 Oct 25;17(43):20301.
29CNA2012diagnosisCroatia312Lijec VjesnEnglish Abstract22930935Vilibi?-Cavlek T, Ljubin-Sternak S, Babi?-Erceg A, Sviben M, Mlinari?-Galinovi? G. Virology diagnosis of re-emergent infections: dengue virus. Lijec Vjesn. 2012 May-Jun;134(5-6):164-7.
30Non-CNA2015dengueCuba311LancetJournal Article25230594Guzman MG, Harris E. Dengue. Lancet. 2015 Jan 31;385(9966):453-65. doi: 10.1016/S0140-6736(14)60572-9. Epub 2014 Sep 14.
31Non-CNA2008transmissionCalifornia308Annu Rev MicrobiolHistorical Article18429680Kyle JL, Harris E. Global spread and persistence of dengue. Annu Rev Microbiol. 2008;62:71-92. doi: 10.1146/annurev.micro.62.081307.163005.
32Non-CNA1988analysisThailand295Am J Trop Med HygJournal Article3341519Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg. 1988 Jan;38(1):172-80. doi: 10.4269/ajtmh.1988.38.172.
33Non-CNA2011immunologyRhode Island292Nat Rev ImmunolJournal Article21760609Rothman AL. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol. 2011 Jul 15;11(8):532-43. doi: 10.1038/nri3014.
34Non-CNA2010immunologySwitzerland279Cell Host MicrobeJournal Article20833378Beltramello M, Williams KL, Simmons CP, Macagno A, Simonelli L, Quyen NT, Sukupolvi-Petty S, Navarro-Sanchez E, Young PR, de Silva AM, Rey FA, Varani L, Whitehead SS, Diamond MS, Harris E, Lanzavecchia A, Sallusto F. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe. 2010 Sep 16;8(3):271-83. doi: 10.1016/j.chom.2010.08.007.
35CNA2002dengueCuba267Lancet Infect DisJournal Article11892494Guzmán MG, Kourí G. Dengue: an update. Lancet Infect Dis. 2002 Jan;2(1):33-42. doi: 10.1016/s1473-3099(01)00171-2.
36Non-CNA2010microbiologyMichigan265PLoS PathogJournal Article20368968Bian G, Xu Y, Lu P, Xie Y, Xi Z. The endosymbiotic bacterium Wolbachia induces resistance to dengue virus in Aedes aegypti. PLoS Pathog. 2010 Apr 1;6(4):e1000833. doi: 10.1371/journal.ppat.1000833.
37Non-CNA2009virologyNetherlands259Clin Microbiol RevJournal Article19822889Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev. 2009 Oct;22(4):564-81. doi: 10.1128/CMR.00035-09.
38Non-CNA2016antibody formationGeorgia259Proc Natl Acad Sci U S AJournal Article27354515Priyamvada L, Quicke KM, Hudson WH, Onlamoon N, Sewatanon J, Edupuganti S, Pattanapanyasat K, Chokephaibulkit K, Mulligan MJ, Wilson PC, Ahmed R, Suthar MS, Wrammert J. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7852-7. doi: 10.1073/pnas.1607931113. Epub 2016 Jun 27.
39Non-CNA2017immunologyCalifornia257ScienceJournal Article29097492Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, Balmaseda A, Harris E. Antibody-dependent enhancement of severe dengue disease in humans. Science. 2017 Nov 17;358(6365):929-932. doi: 10.1126/science.aan6836. Epub 2017 Nov 2
40Non-CNA2010growth & developmentFrance256PLoS Negl Trop DisJournal Article20520794Lambrechts L, Scott TW, Gubler DJ. Consequences of the expanding global distribution of Aedes albopictus for dengue virus transmission. PLoS Negl Trop Dis. 2010 May 25;4(5):e646. doi: 10.1371/journal.pntd.0000646.
41Non-CNA1999statistics & numerical dataBrazil252LancetJournal Article10485724Ko AI, Galvão Reis M, Ribeiro Dourado CM, Johnson WD Jr, Riley LW. Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet. 1999 Sep 4;354(9181):820-5. doi: 10.1016/s0140-6736(99)80012-9.
42CNA1984epidemiology245Am J EpidemiolJournal Article6496446Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, Salitul V, Phanthumachinda B, Halstead SB. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol. 1984 Nov;120(5):653-69. doi: 10.1093/oxfordjournals.aje.a113932.
43Non-CNA2007immunologyMaryland236Nat Rev MicrobiolJournal Article17558424Whitehead SS, Blaney JE, Durbin AP, Murphy BR. Prospects for a dengue virus vaccine. Nat Rev Microbiol. 2007 Jul;5(7):518-28. doi: 10.1038/nrmicro1690.
44Non-CNA2011virologyFrance231Proc Natl Acad Sci U S AJournal Article21502510Lambrechts L, Paaijmans KP, Fansiri T, Carrington LB, Kramer LD, Thomas MB, Scott TW. Impact of daily temperature fluctuations on dengue virus transmission by Aedes aegypti. Proc Natl Acad Sci U S A. 2011 May 3;108(18):7460-5. doi: 10.1073/pnas.1101377108. Epub 2011 Apr 18.
45CNA2004etiologyTexas229Nat Rev MicrobiolJournal Article15378043Weaver SC, Barrett AD. Transmission cycles, host range, evolution and emergence of arboviral disease. Nat Rev Microbiol. 2004 Oct;2(10):789-801. doi: 10.1038/nrmicro1006.
46CNA2008pathogenicityU.K228LancetCase Reports18262042Gould EA, Solomon T. Pathogenic flaviviruses. Lancet. 2008 Feb 9;371(9611):500-9. doi: 10.1016/S0140-6736(08)60238-X.
47Non-CNA2009virologyCalifornia223PLoS Negl Trop DisJournal Article19621090Stoddard ST, Morrison AC, Vazquez-Prokopec GM, Paz Soldan V, Kochel TJ, Kitron U, Elder JP, Scott TW. The role of human movement in the transmission of vector-borne pathogens. PLoS Negl Trop Dis. 2009 Jul 21;3(7):e481. doi: 10.1371/journal.pntd.0000481.
48CNA1987microbiology222Am J Trop Med HygJournal Article3812879Watts DM, Burke DS, Harrison BA, Whitmire RE, Nisalak A. Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus. Am J Trop Med Hyg. 1987 Jan;36(1):143-52. doi: 10.4269/ajtmh.1987.36.143.
49Non-CNA2002transmissionNew Zealand221LancetJournal Article12243917Hales S, de Wet N, Maindonald J, Woodward A. Potential effect of population and climate changes on global distribution of dengue fever: an empirical model. Lancet. 2002 Sep 14;360(9336):830-4. doi: 10.1016/S0140-6736(02)09964-6.
50Non-CNA2012climate changeSweden221EcohealthJournal Article23408100Aström C, Rocklöv J, Hales S, Béguin A, Louis V, Sauerborn R. Potential distribution of dengue fever under scenarios of climate change and economic development. Ecohealth. 2012 Dec;9(4):448-54. doi: 10.1007/s10393-012-0808-0. Epub 2013 Feb 14.
51Non-CNA2002isolation & purificationMassachusetts219J Infect DisJournal Article12355369Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, Vaughn DW, Nisalak A, Ennis FA, Rothman AL. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis. 2002 Oct 15;186(8):1165-8. doi: 10.1086/343813. Epub 2002 Sep 16.
52Non-CNA1988aedesIndiana216J Am Mosq Control Assoc SupplJournal Article3068349Hawley WA. The biology of Aedes albopictus. J Am Mosq Control Assoc Suppl. 1988 Dec;1:1-39.
53Non-CNA1988immunologyDistrict of Columbia216Am J Trop Med HygJournal Article3354774Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg. 1988 Mar;38(2):411-9. doi: 10.4269/ajtmh.1988.38.411.
54CNA1989diagnosisThailand216Am J Trop Med HygJournal Article2540664Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, Puttisri P, Hoke CH. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg. 1989 Apr;40(4):418-27. doi: 10.4269/ajtmh.1989.40.418.
55CNA2013immunologyCalifornia216Proc Natl Acad Sci U S AJournal Article23580623Weiskopf D, Angelo MA, de Azeredo EL, Sidney J, Greenbaum JA, Fernando AN, Broadwater A, Kolla RV, De Silva AD, de Silva AM, Mattia KA, Doranz BJ, Grey HM, Shresta S, Peters B, Sette A. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc Natl Acad Sci U S A. 2013 May 28;110(22):E2046-53. doi: 10.1073/pnas.1305227110. Epub 2013 Apr 11.
56Non-CNA2016immunology215NatureJournal Article27338953Barba-Spaeth G, Dejnirattisai W, Rouvinski A, Vaney MC, Medits I, Sharma A, Simon-Lorière E, Sakuntabhai A, Cao-Lormeau VM, Haouz A, England P, Stiasny K, Mongkolsapaya J, Heinz FX, Screaton GR, Rey FA. Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature. 2016 Aug 4;536(7614):48-53. doi: 10.1038/nature18938. Epub 2016 Jun 23.
57CNA2005physiologyNew York214Am J Trop Med HygJournal Article15741559Harrington LC, Scott TW, Lerdthusnee K, Coleman RC, Costero A, Clark GG, Jones JJ, Kitthawee S, Kittayapong P, Sithiprasasna R, Edman JD. Dispersal of the dengue vector Aedes aegypti within and between rural communities. Am J Trop Med Hyg. 2005 Feb;72(2):209-20.
58Non-CNA2017immunologyNew York213ScienceJournal Article28360135Bardina SV, Bunduc P, Tripathi S, Duehr J, Frere JJ, Brown JA, Nachbagauer R, Foster GA, Krysztof D, Tortorella D, Stramer SL, García-Sastre A, Krammer F, Lim JK. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science. 2017 Apr 14;356(6334):175-180. doi: 10.1126/science.aal4365. Epub 2017 Mar 30
59Non-CNA2013antibody-dependent enhancementCuba212Arch VirolJournal Article23471635Guzman MG, Alvarez M, Halstead SB. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol. 2013 Jul;158(7):1445-59. doi: 10.1007/s00705-013-1645-3. Epub 2013 Mar 8
60Non-CNA2009pharmacologyArgentina209PLoS PathogJournal Article19851456Samsa MM, Mondotte JA, Iglesias NG, Assunção-Miranda I, Barbosa-Lima G, Da Poian AT, Bozza PT, Gamarnik AV. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog. 2009 Oct;5(10):e1000632. doi: 10.1371/journal.ppat.1000632. Epub 2009 Oct 23.
61Non-CNA2002immunologyMassachusetts206J Infect DisJournal Article12001037Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S, Chansiriwongs W, Vaughn DW, Nisalak A, Ennis FA, Rothman AL. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis. 2002 May 1;185(9):1213-21. doi: 10.1086/340365. Epub 2002 Apr 16.
62Non-CNA2008physiologyNetherlands205PLoS PathogJournal Article19096510van der Schaar HM, Rust MJ, Chen C, van der Ende-Metselaar H, Wilschut J, Zhuang X, Smit JM. Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog. 2008 Dec;4(12):e1000244. doi: 10.1371/journal.ppat.1000244. Epub 2008 Dec 19.
63Non-CNA2010immunologyCalifornia203PLoS PathogJournal Article20168989Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, Mehlhop E, Johnson S, Diamond MS, Beatty PR, Harris E. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog. 2010 Feb 12;6(2):e1000790. doi: 10.1371/journal.ppat.1000790.
64Non-CNA2004analysisMalaysia202J Infect DisJournal Article15073678Jessie K, Fong MY, Devi S, Lam SK, Wong KT. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis. 2004 Apr 15;189(8):1411-8. doi: 10.1086/383043. Epub 2004 Apr 5.
65Non-CNA1998denguePuerto Rico200LancetComment9752834Rigau-Pérez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue haemorrhagic fever. Lancet. 1998 Sep 19;352(9132):971-7. doi: 10.1016/s0140-6736(97)12483-7.
66Non-CNA1989physiologyDistrict of Columbia199Am J Trop Med HygJournal Article2712199Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg. 1989 Apr;40(4):444-51. doi: 10.4269/ajtmh.1989.40.444.
67Non-CNA1994epidemiology198Proc Natl Acad Sci U S AJournal Article8146129Monath TP. Dengue: the risk to developed and developing countries. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2395-400. doi: 10.1073/pnas.91.7.2395.
68Non-CNA1976antigen-antibody complex197J Clin InvestJournal Article128562Theofilopoulos AN, Wilson CB, Dixon FJ. The Raji cell radioimmune assay for detecting immune complexes in human sera. J Clin Invest. 1976 Jan;57(1):169-82. doi: 10.1172/JCI108257.
69Non-CNA2016methodsCanada197CellJournal Article27160350Pardee K, Green AA, Takahashi MK, Braff D, Lambert G, Lee JW, Ferrante T, Ma D, Donghia N, Fan M, Daringer NM, Bosch I, Dudley DM, O'Connor DH, Gehrke L, Collins JJ. Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular Components. Cell. 2016 May 19;165(5):1255-1266. doi: 10.1016/j.cell.2016.04.059. Epub 2016 May 6
70Non-CNA2012immunologyNorth Carolina197Proc Natl Acad Sci U S AJournal Article22499787de Alwis R, Smith SA, Olivarez NP, Messer WB, Huynh JP, Wahala WM, White LJ, Diamond MS, Baric RS, Crowe JE Jr, de Silva AM. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc Natl Acad Sci U S A. 2012 May 8;109(19):7439-44. doi: 10.1073/pnas.1200566109. Epub 2012 Apr 12.
71Non-CNA2012microbiologyMichigan190Proc Natl Acad Sci U S AJournal Article22123956Pan X, Zhou G, Wu J, Bian G, Lu P, Raikhel AS, Xi Z. Wolbachia induces reactive oxygen species (ROS)-dependent activation of the Toll pathway to control dengue virus in the mosquito Aedes aegypti. Proc Natl Acad Sci U S A. 2012 Jan 3;109(1):E23-31. doi: 10.1073/pnas.1116932108. Epub 2011 Nov 28.
72Non-CNA2014epidemiologyU.K188Trends MicrobiolHistorical Article24468533Messina JP, Brady OJ, Scott TW, Zou C, Pigott DM, Duda KA, Bhatt S, Katzelnick L, Howes RE, Battle KE, Simmons CP, Hay SI. Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol. 2014 Mar;22(3):138-46. doi: 10.1016/j.tim.2013.12.011. Epub 2014 Jan 24.
73Non-CNA2013transmissionCalifornia188Proc Natl Acad Sci U S AJournal Article23277539Stoddard ST, Forshey BM, Morrison AC, Paz-Soldan VA, Vazquez-Prokopec GM, Astete H, Reiner RC Jr, Vilcarromero S, Elder JP, Halsey ES, Kochel TJ, Kitron U, Scott TW. House-to-house human movement drives dengue virus transmission. Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):994-9. doi: 10.1073/pnas.1213349110. Epub 2012 Dec 31.
74Non-CNA2001culicidaePuerto Rico186Environ Health PerspectJournal Article11250812Reiter P. Climate change and mosquito-borne disease. Environ Health Perspect. 2001 Mar;109 Suppl 1(Suppl 1):141-61. doi: 10.1289/ehp.01109s1141.
75Non-CNA1979immunology185J Infect DisJournal Article117061Halstead SB. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis. 1979 Oct;140(4):527-33. doi: 10.1093/infdis/140.4.527.
76CNA2010bloodFrance185Euro SurveillCase Reports20929659La Ruche G, Souarès Y, Armengaud A, Peloux-Petiot F, Delaunay P, Desprès P, Lenglet A, Jourdain F, Leparc-Goffart I, Charlet F, Ollier L, Mantey K, Mollet T, Fournier JP, Torrents R, Leitmeyer K, Hilairet P, Zeller H, Van Bortel W, Dejour-Salamanca D, Grandadam M, Gastellu-Etchegorry M. First two autochthonous dengue virus infections in metropolitan France, September Euro Surveill. 2010 Sep 30;15(39):19676.
77CNA2011bloodCroatia185Euro SurveillCase Reports21392489Gjenero-Margan I, Aleraj B, Krajcar D, Lesnikar V, Klobu?ar A, Pem-Novosel I, Kure?i?-Filipovi? S, Komparak S, Marti? R, Duri?i? S, Betica-Radi? L, Okmadži? J, Vilibi?-?avlek T, Babi?-Erceg A, Turkovi? B, Avsi?-Županc T, Radi? I, Ljubi? M, Sarac K, Beni? N, Mlinari?-Galinovi? G. Autochthonous dengue fever in Croatia, August-September 2010. Euro Surveill. 2011 Mar 3;16(9):19805.
78Non-CNA2015isolation & purificationU.K180Nat ImmunolJournal Article25501631Dejnirattisai W, Wongwiwat W, Supasa S, Zhang X, Dai X, Rouvinski A, Jumnainsong A, Edwards C, Quyen NTH, Duangchinda T, Grimes JM, Tsai WY, Lai CY, Wang WK, Malasit P, Farrar J, Simmons CP, Zhou ZH, Rey FA, Mongkolsapaya J, Screaton GR. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol. 2015 Feb;16(2):170-177. doi: 10.1038/ni.3058. Epub 2014 Dec 15.
79CNA2006virologySingapore180Emerg Infect DisJournal Article16707042Ooi EE, Goh KT, Gubler DJ. Dengue prevention and 35 years of vector control in Singapore. Emerg Infect Dis. 2006 Jun;12(6):887-93. doi: 10.3201/10.3201/eid1206.051210.
80Non-CNA1997virologyConnecticut179VirologyJournal Article9143280Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, Ramos C, Boshell J, de Mesa MT, Nogueira RM, da Rosa AT. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology. 1997 Apr 14;230(2):244-51. doi: 10.1006/viro.1997.8504.
81Non-CNA2011immunologyMaryland179Annu Rev ImmunolJournal Article21219187Murphy BR, Whitehead SS. Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol. 2011;29:587-619. doi: 10.1146/annurev-immunol-031210-101315.
82Non-CNA2002diagnosisFrance178J Clin MicrobiolEvaluation Study11825945Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol. 2002 Feb;40(2):376-81. doi: 10.1128/jcm.40.02.376-381.2002.
83CNA2010epidemiologyPanama178Am J Trop Med HygJournal Article20065008San Martín JL, Brathwaite O, Zambrano B, Solórzano JO, Bouckenooghe A, Dayan GH, Guzmán MG. The epidemiology of dengue in the americas over the last three decades: a worrisome reality. Am J Trop Med Hyg. 2010 Jan;82(1):128-35. doi: 10.4269/ajtmh.2010.09-0346.
84Non-CNA2006capillary permeabilityCalifornia175J VirolJournal Article17005698Shresta S, Sharar KL, Prigozhin DM, Beatty PR, Harris E. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol. 2006 Oct;80(20):10208-17. doi: 10.1128/JVI.00062-06.
85Non-CNA2006physiologyThailand167J Infect DisComparative Study16544248Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K, Jairungsri A, Kanlaya R, Tangthawornchaikul N, Puttikhunt C, Pattanakitsakul SN, Yenchitsomanus PT, Mongkolsapaya J, Kasinrerk W, Sittisombut N, Husmann M, Blettner M, Vasanawathana S, Bhakdi S, Malasit P. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis. 2006 Apr 15;193(8):1078-88. doi: 10.1086/500949. Epub 2006 Mar 9.
86Non-CNA2000diagnosisVietnam167LancetJournal Article10744091Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LT, Raengsakulrach B, Loan HT, Day NP, Farrar J, Myint KS, Warrell MJ, James WS, Nisalak A, White NJ. Neurological manifestations of dengue infection. Lancet. 2000 Mar 25;355(9209):1053-9. doi: 10.1016/S0140-6736(00)02036-5.
87Non-CNA2012physiologyGeorgia167PLoS OneJournal Article23226436Chan M, Johansson MA. The incubation periods of Dengue viruses. PLoS One. 2012;7(11):e50972. doi: 10.1371/journal.pone.0050972. Epub 2012 Nov 30.
88Non-CNA2010immunologyCalifornia161Cell Host MicrobeJournal Article20153282Zellweger RM, Prestwood TR, Shresta S. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe. 2010 Feb 18;7(2):128-39. doi: 10.1016/j.chom.2010.01.004.
89Non-CNA2007immunologyMaryland159Proc Natl Acad Sci U S AJournal Article17517625Goncalvez AP, Engle RE, St Claire M, Purcell RH, Lai CJ. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc Natl Acad Sci U S A. 2007 May 29;104(22):9422-7. doi: 10.1073/pnas.0703498104. Epub 2007 May 15.
90CNA2003bloodThailand157Am J Trop Med HygJournal Article12641411Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn U, Scott RM, Burke DS, Hoke CH, Innis BL, Vaughn DW. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg. 2003 Feb;68(2):191-202.
91Non-CNA1995epidemiologyColorado156Emerg Infect DisHistorical Article8903160Gubler DJ, Clark GG. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis. 1995 Apr-Jun;1(2):55-7. doi: 10.3201/eid0102.952004.
92CNA2004epidemiologyMaryland155NatureJournal Article14737166Cummings DA, Irizarry RA, Huang NE, Endy TP, Nisalak A, Ungchusak K, Burke DS. Travelling waves in the occurrence of dengue haemorrhagic fever in Thailand. Nature. 2004 Jan 22;427(6972):344-7. doi: 10.1038/nature02225.
93CNA2015immunologySingapore155ScienceJournal Article26138103Manokaran G, Finol E, Wang C, Gunaratne J, Bahl J, Ong EZ, Tan HC, Sessions OM, Ward AM, Gubler DJ, Harris E, Garcia-Blanco MA, Ooi EE. Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness. Science. 2015 Oct 9;350(6257):217-21. doi: 10.1126/science.aab3369. Epub 2015 Jul 2.
94Non-CNA2004bloodMaryland154J Infect DisJournal Article14999601Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, Ennis FA, Rothman AL, Libraty DH. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis. 2004 Mar 15;189(6):990-1000. doi: 10.1086/382280. Epub 2004 Mar 1.
95Non-CNA2004immunologyCalifornia152J VirolJournal Article14990690Shresta S, Kyle JL, Snider HM, Basavapatna M, Beatty PR, Harris E. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol. 2004 Mar;78(6):2701-10. doi: 10.1128/jvi.78.6.2701-2710.2004.
96Non-CNA2009geneticsTexas151Infect Genet EvolJournal Article19460319Weaver SC, Vasilakis N. Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease. Infect Genet Evol. 2009 Jul;9(4):523-40. doi: 10.1016/j.meegid.2009.02.003. Epub 2009 Feb 13.
97Non-CNA2005virology149J Clin MicrobiolEvaluation Study16207951Johnson BW, Russell BJ, Lanciotti RS. Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay. J Clin Microbiol. 2005 Oct;43(10):4977-83. doi: 10.1128/JCM.43.10.4977-4983.2005.
98Non-CNA2016economicsMassachusetts149Lancet Infect DisJournal Article27091092Shepard DS, Undurraga EA, Halasa YA, Stanaway JD. The global economic burden of dengue: a systematic analysis. Lancet Infect Dis. 2016 Aug;16(8):935-41. doi: 10.1016/S1473-3099(16)00146-8. Epub 2016 Apr 16.
99Non-CNA2011economicsMassachusetts149Am J Trop Med HygJournal Article21292885Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH. Economic impact of dengue illness in the Americas. Am J Trop Med Hyg. 2011 Feb;84(2):200-7. doi: 10.4269/ajtmh.2011.10-0503.
100CNA2001climateColorado149Environ Health PerspectJournal Article11359689Gubler DJ, Reiter P, Ebi KL, Yap W, Nasci R, Patz JA. Climate variability and change in the United States: potential impacts on vector- and rodent-borne diseases. Environ Health Perspect. 2001 May;109 Suppl 2(Suppl 2):223-33. doi: 10.1289/ehp.109-1240669.
101CNA1997diagnosisThailand149J Infect DisJournal Article9237695Kalayanarooj S, Vaughn DW, Nimmannitya S, Green S, Suntayakorn S, Kunentrasai N, Viramitrachai W, Ratanachu-eke S, Kiatpolpoj S, Innis BL, Rothman AL, Nisalak A, Ennis FA. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis. 1997 Aug;176(2):313-21. doi: 10.1086/514047.
102Non-CNA2008virologyMaryland148Annu Rev EntomolJournal Article17803458Halstead SB. Dengue virus-mosquito interactions. Annu Rev Entomol. 2008;53:273-91. doi: 10.1146/annurev.ento.53.103106.093326.
103Non-CNA2000diagnosisAustralia146J Clin MicrobiolJournal Article10698995Young PR, Hilditch PA, Bletchly C, Halloran W. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol. 2000 Mar;38(3):1053-7. doi: 10.1128/JCM.38.3.1053-1057.2000.
104CNA2002epidemiologyU.S146Am J EpidemiolJournal Article12076887Endy TP, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, Rothman AL, Vaughn DW, Ennis FA. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol. 2002 Jul 1;156(1):40-51. doi: 10.1093/aje/kwf005.
105Non-CNA2018chemistryMassachusetts145ScienceEvaluation Study29700266Myhrvold C, Freije CA, Gootenberg JS, Abudayyeh OO, Metsky HC, Durbin AF, Kellner MJ, Tan AL, Paul LM, Parham LA, Garcia KF, Barnes KG, Chak B, Mondini A, Nogueira ML, Isern S, Michael SF, Lorenzana I, Yozwiak NL, MacInnis BL, Bosch I, Gehrke L, Zhang F, Sabeti PC. Field-deployable viral diagnostics using CRISPR-Cas13. Science. 2018 Apr 27;360(6387):444-448. doi: 10.1126/science.aas8836.
106Non-CNA2015transmissionCambodia145Proc Natl Acad Sci U S AJournal Article26553981Duong V, Lambrechts L, Paul RE, Ly S, Lay RS, Long KC, Huy R, Tarantola A, Scott TW, Sakuntabhai A, Buchy P. Asymptomatic humans transmit dengue virus to mosquitoes. Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14688-93. doi: 10.1073/pnas.1508114112. Epub 2015 Nov 9.
107Non-CNA2013anatomy & histologyConnecticut144Mem Inst Oswaldo CruzJournal Article24473798Powell JR, Tabachnick WJ. History of domestication and spread of Aedes aegypti--a review. Mem Inst Oswaldo Cruz. 2013;108 Suppl 1(Suppl 1):11-7. doi: 10.1590/0074-0276130395.
108Non-CNA2008bloodBrazil141BMC Infect DisEvaluation Study18578883Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, Assis EF, Bozza PT, Kubelka CF. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis. 2008 Jun 25;8:86. doi: 10.1186/1471-2334-8-86.
109CNA2003classificationNorth Carolina140Emerg Infect DisJournal Article12899133Messer WB, Gubler DJ, Harris E, Sivananthan K, de Silva AM. Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis. 2003 Jul;9(7):800-9. doi: 10.3201/eid0907.030038.
110Non-CNA1990microbiologyWashington139Clin Microbiol RevJournal Article2224837Henchal EA, Putnak JR. The dengue viruses. Clin Microbiol Rev. 1990 Oct;3(4):376-96. doi: 10.1128/cmr.3.4.376.
111CNA2015geneticsU.K139PLoS Negl Trop DisEvaluation Study26135160Carvalho DO, McKemey AR, Garziera L, Lacroix R, Donnelly CA, Alphey L, Malavasi A, Capurro ML. Suppression of a Field Population of Aedes aegypti in Brazil by Sustained Release of Transgenic Male Mosquitoes. PLoS Negl Trop Dis. 2015 Jul 2;9(7):e0003864. doi: 10.1371/journal.pntd.0003864. eCollection 2015.
112Non-CNA1995computer simulationFlorida138Am J Trop Med HygJournal Article7485707Focks DA, Daniels E, Haile DG, Keesling JE. A simulation model of the epidemiology of urban dengue fever: literature analysis, model development, preliminary validation, and samples of simulation results. Am J Trop Med Hyg. 1995 Nov;53(5):489-506. doi: 10.4269/ajtmh.1995.53.489.
113CNA2011pathologyCalifornia136Sci Transl MedJournal Article22190239OhAinle M, Balmaseda A, Macalalad AR, Tellez Y, Zody MC, Saborío S, Nuñez A, Lennon NJ, Birren BW, Gordon A, Henn MR, Harris E. Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci Transl Med. 2011 Dec 21;3(114):114ra128. doi: 10.1126/scitranslmed.3003084.
114Non-CNA2003virologyTexas135Adv Virus ResJournal Article14696333Rico-Hesse R. Microevolution and virulence of dengue viruses. Adv Virus Res. 2003;59:315-41. doi: 10.1016/s0065-3527(03)59009-1.
115Non-CNA1997bloodThailand135J Infect DisJournal Article9237696Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Rothman AL, Ennis FA, Nisalak A. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis. 1997 Aug;176(2):322-30. doi: 10.1086/514048.
116Non-CNA1997virologyColorado135VirologyJournal Article9143286Kinney RM, Butrapet S, Chang GJ, Tsuchiya KR, Roehrig JT, Bhamarapravati N, Gubler DJ. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology. 1997 Apr 14;230(2):300-8. doi: 10.1006/viro.1997.8500.
117Non-CNA2018epidemiologyColorado135MMWR Morb Mortal Wkly RepJournal Article29723166Rosenberg R, Lindsey NP, Fischer M, Gregory CJ, Hinckley AF, Mead PS, Paz-Bailey G, Waterman SH, Drexler NA, Kersh GJ, Hooks H, Partridge SK, Visser SN, Beard CB, Petersen LR. Vital Signs: Trends in Reported Vectorborne Disease Cases - United States and Territories, 2004-2016. MMWR Morb Mortal Wkly Rep. 2018 May 4;67(17):496-501. doi: 10.15585/mmwr.mm6717e1.
118Non-CNA2012microbiologyU.K135Proc Natl Acad Sci U S AJournal Article22123944Blagrove MS, Arias-Goeta C, Failloux AB, Sinkins SP. Wolbachia strain wMel induces cytoplasmic incompatibility and blocks dengue transmission in Aedes albopictus. Proc Natl Acad Sci U S A. 2012 Jan 3;109(1):255-60. doi: 10.1073/pnas.1112021108. Epub 2011 Nov 28.
119Non-CNA2008epidemiologyThailand134PLoS MedJournal Article18986209Mammen MP, Pimgate C, Koenraadt CJ, Rothman AL, Aldstadt J, Nisalak A, Jarman RG, Jones JW, Srikiatkhachorn A, Ypil-Butac CA, Getis A, Thammapalo S, Morrison AC, Libraty DH, Green S, Scott TW. Spatial and temporal clustering of dengue virus transmission in Thai villages. PLoS Med. 2008 Nov 4;5(11):e205. doi: 10.1371/journal.pmed.0050205.
120Non-CNA2012epidemiologyThailand134J Infect DisJournal Article22615312Yoon IK, Rothman AL, Tannitisupawong D, Srikiatkhachorn A, Jarman RG, Aldstadt J, Nisalak A, Mammen MP Jr, Thammapalo S, Green S, Libraty DH, Gibbons RV, Getis A, Endy T, Jones JW, Koenraadt CJ, Morrison AC, Fansiri T, Pimgate C, Scott TW. Underrecognized mildly symptomatic viremic dengue virus infections in rural Thai schools and villages. J Infect Dis. 2012 Aug 1;206(3):389-98. doi: 10.1093/infdis/jis357. Epub 2012 May 21
121Non-CNA2006immunologyMassachusetts132Curr Opin Infect DisJournal Article16940865Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis. 2006 Oct;19(5):429-36. doi: 10.1097/01.qco.0000244047.31135.fa.
122Non-CNA1974analysis132Allerg Immunol (Leipz)Journal Article4283486Nishioka K. Serum complement level in dengue hemorrhagic fever. Allerg Immunol (Leipz). 1974-1975;20-21(4):385-92.
123Non-CNA2012microbiologyMaryland132PLoS Negl Trop DisJournal Article22413032Ramirez JL, Souza-Neto J, Torres Cosme R, Rovira J, Ortiz A, Pascale JM, Dimopoulos G. Reciprocal tripartite interactions between the Aedes aegypti midgut microbiota, innate immune system and dengue virus influences vector competence. PLoS Negl Trop Dis. 2012;6(3):e1561. doi: 10.1371/journal.pntd.0001561. Epub 2012 Mar 6.
124CNA2012microbiologyBrazil131Mem Inst Oswaldo CruzJournal Article22990977Maciel-de-Freitas R, Aguiar R, Bruno RV, Guimarães MC, Lourenço-de-Oliveira R, Sorgine MH, Struchiner CJ, Valle D, O'Neill SL, Moreira LA. Why do we need alternative tools to control mosquito-borne diseases in Latin America? Mem Inst Oswaldo Cruz. 2012 Sep;107(6):828-9. doi: 10.1590/s0074-02762012000600021.
125CNA2011microbiologyAustralia131EMBO RepJournal Article21546911Iturbe-Ormaetxe I, Walker T, O' Neill SL. Wolbachia and the biological control of mosquito-borne disease. EMBO Rep. 2011 Jun;12(6):508-18. doi: 10.1038/embor.2011.84. Epub 2011 May 6.
126Non-CNA2011genetics130Nat BiotechnolComment22068534Shelly T, McInnis D. Road test for genetically modified mosquitoes. Nat Biotechnol. 2011 Nov 8;29(11):984-5. doi: 10.1038/nbt.2025.
127Non-CNA2011geneticsCayman Islands130Nat BiotechnolJournal Article22037376Harris AF, Nimmo D, McKemey AR, Kelly N, Scaife S, Donnelly CA, Beech C, Petrie WD, Alphey L. Field performance of engineered male mosquitoes. Nat Biotechnol. 2011 Oct 30;29(11):1034-7. doi: 10.1038/nbt.2019.
128CNA2003transmissionColorado130Emerg Infect DisJournal Article12533286Reiter P, Lathrop S, Bunning M, Biggerstaff B, Singer D, Tiwari T, Baber L, Amador M, Thirion J, Hayes J, Seca C, Mendez J, Ramirez B, Robinson J, Rawlings J, Vorndam V, Waterman S, Gubler D, Clark G, Hayes E. Texas lifestyle limits transmission of dengue virus. Emerg Infect Dis. 2003 Jan;9(1):86-9. doi: 10.3201/eid0901.020220.
129Non-CNA2018prevention & controlFrance129N Engl J MedJournal Article29897841Sridhar S, Luedtke A, Langevin E, Zhu M, Bonaparte M, Machabert T, Savarino S, Zambrano B, Moureau A, Khromava A, Moodie Z, Westling T, Mascareñas C, Frago C, Cortés M, Chansinghakul D, Noriega F, Bouckenooghe A, Chen J, Ng SP, Gilbert PB, Gurunathan S, DiazGranados CA. Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy. N Engl J Med. 2018 Jul 26;379(4):327-340. doi: 10.1056/NEJMoa1800820. Epub 2018 Jun 13
130Non-CNA2015virologyIndiana126PLoS Negl Trop DisJournal Article25951103Achee NL, Gould F, Perkins TA, Reiner RC Jr, Morrison AC, Ritchie SA, Gubler DJ, Teyssou R, Scott TW. A critical assessment of vector control for dengue prevention. PLoS Negl Trop Dis. 2015 May 7;9(5):e0003655. doi: 10.1371/journal.pntd.0003655. eCollection 2015 May.
131Non-CNA2012immunologyAustralia126PLoS PathogJournal Article22383881Rancès E, Ye YH, Woolfit M, McGraw EA, O'Neill SL. The relative importance of innate immune priming in Wolbachia-mediated dengue interference. PLoS Pathog. 2012 Feb;8(2):e1002548. doi: 10.1371/journal.ppat.1002548. Epub 2012 Feb 23.
132Non-CNA2013diagnosisPuerto Rico125PLoS Negl Trop DisEvaluation Study23875046Santiago GA, Vergne E, Quiles Y, Cosme J, Vazquez J, Medina JF, Medina F, Colón C, Margolis H, Muñoz-Jordán JL. Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus. PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2311. doi: 10.1371/journal.pntd.0002311. Print 2013
133Non-CNA2012historyDistrict of Columbia125Am J Trop Med HygHistorical Article23042846Brathwaite Dick O, San Martín JL, Montoya RH, del Diego J, Zambrano B, Dayan GH. The history of dengue outbreaks in the Americas. Am J Trop Med Hyg. 2012 Oct;87(4):584-93. doi: 10.4269/ajtmh.2012.11-0770.
134Non-CNA2011immunologyNorth Carolina125VirusesJournal Article22355444Wahala WM, Silva AM. The human antibody response to dengue virus infection. Viruses. 2011 Dec;3(12):2374-95. doi: 10.3390/v3122374. Epub 2011 Nov 25.
135Non-CNA2006immunologyU.K124J ImmunolJournal Article16517753Mongkolsapaya J, Duangchinda T, Dejnirattisai W, Vasanawathana S, Avirutnan P, Jairungsri A, Khemnu N, Tangthawornchaikul N, Chotiyarnwong P, Sae-Jang K, Koch M, Jones Y, McMichael A, Xu X, Malasit P, Screaton G. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? J Immunol. 2006 Mar 15;176(6):3821-9. doi: 10.4049/jimmunol.176.6.3821.
136Non-CNA1999immunologyMassachusetts124J Infect DisJournal Article10068569Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Lew R, Innis BL, Kurane I, Rothman AL, Ennis FA. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis. 1999 Apr;179(4):755-62. doi: 10.1086/314680.
137Non-CNA2012therapeutic useSingapore124Sci Transl MedJournal Article22723463Teoh EP, Kukkaro P, Teo EW, Lim AP, Tan TT, Yip A, Schul W, Aung M, Kostyuchenko VA, Leo YS, Chan SH, Smith KG, Chan AH, Zou G, Ooi EE, Kemeny DM, Tan GK, Ng JK, Ng ML, Alonso S, Fisher D, Shi PY, Hanson BJ, Lok SM, MacAry PA. The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci Transl Med. 2012 Jun 20;4(139):139ra83. doi: 10.1126/scitranslmed.3003888.
138Non-CNA2008epidemiologySingapore123Med Clin North AmJournal Article19061757Wilder-Smith A, Gubler DJ. Geographic expansion of dengue: the impact of international travel. Med Clin North Am. 2008 Nov;92(6):1377-90, x. doi: 10.1016/j.mcna.2008.07.002.
139Non-CNA1989biosynthesisNew York123Rev Infect DisJournal Article2665015Halstead SB. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S830-9. doi: 10.1093/clinids/11.supplement_4.s830.
140Non-CNA1996immunologyMaryland122J VirolJournal Article8648730Men R, Bray M, Clark D, Chanock RM, Lai CJ. Dengue type 4 virus mutants containing deletions in the 3' noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys. J Virol. 1996 Jun;70(6):3930-7. doi: 10.1128/JVI.70.6.3930-3937.1996.
141CNA1997complicationsMyanmar122Am J Trop Med HygJournal Article9180609Thein S, Aung MM, Shwe TN, Aye M, Zaw A, Aye K, Aye KM, Aaskov J. Risk factors in dengue shock syndrome. Am J Trop Med Hyg. 1997 May;56(5):566-72. doi: 10.4269/ajtmh.1997.56.566.
142CNA2015epidemiologyMassachusetts122Proc Natl Acad Sci U S AJournal Article26351662Wesolowski A, Qureshi T, Boni MF, Sundsøy PR, Johansson MA, Rasheed SB, Engø-Monsen K, Buckee CO. Impact of human mobility on the emergence of dengue epidemics in Pakistan. Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11887-92. doi: 10.1073/pnas.1504964112. Epub 2015 Sep 8.
143Non-CNA2009pharmacologySingapore121Proc Natl Acad Sci U S AJournal Article19918064Yin Z, Chen YL, Schul W, Wang QY, Gu F, Duraiswamy J, Kondreddi RR, Niyomrattanakit P, Lakshminarayana SB, Goh A, Xu HY, Liu W, Liu B, Lim JY, Ng CY, Qing M, Lim CC, Yip A, Wang G, Chan WL, Tan HP, Lin K, Zhang B, Zou G, Bernard KA, Garrett C, Beltz K, Dong M, Weaver M, He H, Pichota A, Dartois V, Keller TH, Shi PY. An adenosine nucleoside inhibitor of dengue virus. Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20435-9. doi: 10.1073/pnas.0907010106. Epub 2009 Nov 16.
144Non-CNA2012metabolismTaiwan121PLoS PathogJournal Article22761576Yu CY, Chang TH, Liang JJ, Chiang RL, Lee YL, Liao CL, Lin YL. Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog. 2012;8(6):e1002780. doi: 10.1371/journal.ppat.1002780. Epub 2012 Jun 28
145CNA2009economicsMassachusetts121Am J Trop Med HygJournal Article19407136Suaya JA, Shepard DS, Siqueira JB, Martelli CT, Lum LC, Tan LH, Kongsin S, Jiamton S, Garrido F, Montoya R, Armien B, Huy R, Castillo L, Caram M, Sah BK, Sughayyar R, Tyo KR, Halstead SB. Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. Am J Trop Med Hyg. 2009 May;80(5):846-55.
146Non-CNA1999genetics120Mol Biol EvolJournal Article10331266Holmes EC, Worobey M, Rambaut A. Phylogenetic evidence for recombination in dengue virus. Mol Biol Evol. 1999 Mar;16(3):405-9. doi: 10.1093/oxfordjournals.molbev.a026121.
147Non-CNA2013complicationsU.K120Lancet NeurolJournal Article23948177Carod-Artal FJ, Wichmann O, Farrar J, Gascón J. Neurological complications of dengue virus infection. Lancet Neurol. 2013 Sep;12(9):906-919. doi: 10.1016/S1474-4422(13)70150-9.
148Non-CNA2012complicationsFrance120Presse MedEnglish Abstract22534135Oehler E, Le Hénaff O, Ghawche F. Neurological manifestations of dengue. Presse Med. 2012 Oct;41(10):e547-52. doi: 10.1016/j.lpm.2012.03.010. Epub 2012 Apr 24
149CNA2003physiologyCalifornia120Am J Trop Med HygJournal Article14695086Getis A, Morrison AC, Gray K, Scott TW. Characteristics of the spatial pattern of the dengue vector, Aedes aegypti, in Iquitos, Peru. Am J Trop Med Hyg. 2003 Nov;69(5):494-505.
150Non-CNA2010growth & developmentNetherlands118Cell Mol Life SciJournal Article20372965Rodenhuis-Zybert IA, Wilschut J, Smit JM. Dengue virus life cycle: viral and host factors modulating infectivity. Cell Mol Life Sci. 2010 Aug;67(16):2773-86. doi: 10.1007/s00018-010-0357-z. Epub 2010 Apr 6.
151Non-CNA2010geneticsU.K118Proc Natl Acad Sci U S AJournal Article20176967Fu G, Lees RS, Nimmo D, Aw D, Jin L, Gray P, Berendonk TU, White-Cooper H, Scaife S, Kim Phuc H, Marinotti O, Jasinskiene N, James AA, Alphey L. Female-specific flightless phenotype for mosquito control. Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4550-4. doi: 10.1073/pnas.1000251107. Epub 2010 Feb 22.
152Non-CNA2006dengueGeorgia118Proc Natl Acad Sci U S AJournal Article16868086Wearing HJ, Rohani P. Ecological and immunological determinants of dengue epidemics. Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11802-7. doi: 10.1073/pnas.0602960103. Epub 2006 Jul 25.
153Non-CNA2004epidemiologyHawaii118Comp Immunol Microbiol Infect DisJournal Article15225982Gubler DJ. The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle? Comp Immunol Microbiol Infect Dis. 2004 Sep;27(5):319-30. doi: 10.1016/j.cimid.2004.03.013.
154Non-CNA2012epidemiology118Emerg Infect DisLetter22305127de Laval F, Plumet S, Simon F, Deparis X, Leparc-Goffart I. Dengue surveillance among French military in Africa. Emerg Infect Dis. 2012 Feb;18(2):342-3. doi: 10.3201/eid1802.111333.
155Non-CNA2012prevention & control118LancetLetter22189046Lam SK, Burke D, Gubler D, Méndez-Gálvan J, Thomas L. Call for a World Dengue Day. Lancet. 2012 Feb 4;379(9814):411-2. doi: 10.1016/S0140-6736(11)61922-3. Epub 2011 Dec 19.
156Non-CNA2011immunologyBrazil118BiosystemsJournal Article21839800Amaku M, Coutinho FA, Massad E. Why dengue and yellow fever coexist in some areas of the world and not in others? Biosystems. 2011 Nov;106(2-3):111-20. doi: 10.1016/j.biosystems.2011.07.004. Epub 2011 Aug 2.
157Non-CNA2011epidemiologySouth Korea118Emerg Infect DisJournal Article21801609Amarasinghe A, Kuritsk JN, Letson GW, Margolis HS. Dengue virus infection in Africa. Emerg Infect Dis. 2011 Aug;17(8):1349-54. doi: 10.3201/eid1708.101515.
158Non-CNA2000aedesAustralia117Med Vet EntomolJournal Article10759309Tun-Lin W, Burkot TR, Kay BH. Effects of temperature and larval diet on development rates and survival of the dengue vector Aedes aegypti in north Queensland, Australia. Med Vet Entomol. 2000 Mar;14(1):31-7. doi: 10.1046/j.1365-2915.2000.00207.x.
159Non-CNA1999immunologyMassachusetts117VirologyJournal Article10208914Rothman AL, Ennis FA. Immunopathogenesis of Dengue hemorrhagic fever. Virology. 1999 Apr 25;257(1):1-6. doi: 10.1006/viro.1999.9656.
160Non-CNA2017transmissionCalifornia117PLoS Negl Trop DisJournal Article28448507Mordecai EA, Cohen JM, Evans MV, Gudapati P, Johnson LR, Lippi CA, Miazgowicz K, Murdock CC, Rohr JR, Ryan SJ, Savage V, Shocket MS, Stewart Ibarra A, Thomas MB, Weikel DP. Detecting the impact of temperature on transmission of Zika, dengue, and chikungunya using mechanistic models. PLoS Negl Trop Dis. 2017 Apr 27;11(4):e0005568. doi: 10.1371/journal.pntd.0005568. eCollection 2017 Apr.
161Non-CNA2013drug effectsFrance117Philos Trans R Soc Lond B Biol SciJournal Article23297352David JP, Ismail HM, Chandor-Proust A, Paine MJ. Role of cytochrome P450s in insecticide resistance: impact on the control of mosquito-borne diseases and use of insecticides on Earth. Philos Trans R Soc Lond B Biol Sci. 2013 Jan 6;368(1612):20120429. doi: 10.1098/rstb.2012.0429. Print 2013 Feb 19.
162Non-CNA2014virologySweden116PLoS OneJournal Article24603439Liu-Helmersson J, Stenlund H, Wilder-Smith A, Rocklöv J. Vectorial capacity of Aedes aegypti: effects of temperature and implications for global dengue epidemic potential. PLoS One. 2014 Mar 6;9(3):e89783. doi: 10.1371/journal.pone.0089783. eCollection 2014
163Non-CNA2011immunologySingapore116PLoS Negl Trop DisJournal Article21245912Nasirudeen AM, Wong HH, Thien P, Xu S, Lam KP, Liu DX. RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl Trop Dis. 2011 Jan 4;5(1):e926. doi: 10.1371/journal.pntd.0000926.
164Non-CNA2011virologyBrazil116BiosystemsJournal Article21093536Yang HM, Macoris Mde L, Galvani KC, Andrighetti MT. Follow up estimation of Aedes aegypti entomological parameters and mathematical modellings. Biosystems. 2011 Mar;103(3):360-71. doi: 10.1016/j.biosystems.2010.11.002. Epub 2010 Nov 17.
165CNA2002virologyColorado115Am J Trop Med HygJournal Article12363070Bennett KE, Olson KE, Muñoz Mde L, Fernandez-Salas I, Farfan-Ale JA, Higgs S, Black WC 4th, Beaty BJ. Variation in vector competence for dengue 2 virus among 24 collections of Aedes aegypti from Mexico and the United States. Am J Trop Med Hyg. 2002 Jul;67(1):85-92. doi: 10.4269/ajtmh.2002.67.85.
166CNA2000growth & developmentFlorida115Am J Trop Med HygJournal Article10761719Focks DA, Brenner RJ, Hayes J, Daniels E. Transmission thresholds for dengue in terms of Aedes aegypti pupae per person with discussion of their utility in source reduction efforts. Am J Trop Med Hyg. 2000 Jan;62(1):11-8.
167Non-CNA2010immunologyNetherlands114PLoS PathogJournal Article20062797Rodenhuis-Zybert IA, van der Schaar HM, da Silva Voorham JM, van der Ende-Metselaar H, Lei HY, Wilschut J, Smit JM. Immature dengue virus: a veiled pathogen? PLoS Pathog. 2010 Jan;6(1):e1000718. doi: 10.1371/journal.ppat.1000718. Epub 2010 Jan 8.
168Non-CNA2005climateFrance114PLoS MedJournal Article15839751Cazelles B, Chavez M, McMichael AJ, Hales S. Nonstationary influence of El Niño on the synchronous dengue epidemics in Thailand. PLoS Med. 2005 Apr;2(4):e106. doi: 10.1371/journal.pmed.0020106. Epub 2005 Apr 26.
169CNA2005epidemiologyCalifornia114Am J Trop Med HygJournal Article16354813Hammond SN, Balmaseda A, Pérez L, Tellez Y, Saborío SI, Mercado JC, Videa E, Rodriguez Y, Pérez MA, Cuadra R, Solano S, Rocha J, Idiaquez W, Gonzalez A, Harris E. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg. 2005 Dec;73(6):1063-70.
170Non-CNA2013bloodCalifornia113Cell Host MicrobeJournal Article23768493Parameswaran P, Liu Y, Roskin KM, Jackson KK, Dixit VP, Lee JY, Artiles KL, Zompi S, Vargas MJ, Simen BB, Hanczaruk B, McGowan KR, Tariq MA, Pourmand N, Koller D, Balmaseda A, Boyd SD, Harris E, Fire AZ. Convergent antibody signatures in human dengue. Cell Host Microbe. 2013 Jun 12;13(6):691-700. doi: 10.1016/j.chom.2013.05.008.
171CNA2013cross protectionMassachusetts113J R Soc InterfaceJournal Article23825116Reich NG, Shrestha S, King AA, Rohani P, Lessler J, Kalayanarooj S, Yoon IK, Gibbons RV, Burke DS, Cummings DA. Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity. J R Soc Interface. 2013 Jul 3;10(86):20130414. doi: 10.1098/rsif.2013.0414. Print 2013 Sep 6.
172Non-CNA2006virologyAustralia111ScienceJournal Article16410525Aaskov J, Buzacott K, Thu HM, Lowry K, Holmes EC. Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes. Science. 2006 Jan 13;311(5758):236-8. doi: 10.1126/science.1115030.
173Non-CNA2016growth & developmentU.K111PLoS Negl Trop DisJournal Article26986468Bowman LR, Donegan S, McCall PJ. Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis. PLoS Negl Trop Dis. 2016 Mar 17;10(3):e0004551. doi: 10.1371/journal.pntd.0004551. eCollection 2016 Mar.
174Non-CNA2015immunologyCalifornia111Proc Natl Acad Sci U S AJournal Article26195744Weiskopf D, Bangs DJ, Sidney J, Kolla RV, De Silva AD, de Silva AM, Crotty S, Peters B, Sette A. Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity. Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):E4256-63. doi: 10.1073/pnas.1505956112. Epub 2015 Jul 20.
175Non-CNA2007virologyNetherlands110J VirolJournal Article17728239van der Schaar HM, Rust MJ, Waarts BL, van der Ende-Metselaar H, Kuhn RJ, Wilschut J, Zhuang X, Smit JM. Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol. 2007 Nov;81(21):12019-28. doi: 10.1128/JVI.00300-07. Epub 2007 Aug 29.
176Non-CNA2005epidemiologyHawaii110Emerg Infect DisJournal Article15890132Effler PV, Pang L, Kitsutani P, Vorndam V, Nakata M, Ayers T, Elm J, Tom T, Reiter P, Rigau-Perez JG, Hayes JM, Mills K, Napier M, Clark GG, Gubler DJ. Dengue fever, Hawaii, 2001-2002. Emerg Infect Dis. 2005 May;11(5):742-9. doi: 10.3201/eid1105.041063.
177Non-CNA2016drug effectsItaly110Parasitol ResJournal Article26932263Benelli G, Mehlhorn H. Declining malaria, rising of dengue and Zika virus: insights for mosquito vector control. Parasitol Res. 2016 May;115(5):1747-54. doi: 10.1007/s00436-016-4971-z. Epub 2016 Mar 2.
178Non-CNA2010physiologyMaryland109PLoS PathogJournal Article20949067Zaitseva E, Yang ST, Melikov K, Pourmal S, Chernomordik LV. Dengue virus ensures its fusion in late endosomes using compartment-specific lipids. PLoS Pathog. 2010 Oct 7;6(10):e1001131. doi: 10.1371/journal.ppat.1001131.
179Non-CNA2004immunologyMassachusetts109J Clin InvestJournal Article15057297Rothman AL. Dengue: defining protective versus pathologic immunity. J Clin Invest. 2004 Apr;113(7):946-51. doi: 10.1172/JCI21512.
180Non-CNA2014physiologyU.K109Parasit VectorsJournal Article25052008Brady OJ, Golding N, Pigott DM, Kraemer MU, Messina JP, Reiner RC Jr, Scott TW, Smith DL, Gething PW, Hay SI. Global temperature constraints on Aedes aegypti and Ae. albopictus persistence and competence for dengue virus transmission. Parasit Vectors. 2014 Jul 22;7:338. doi: 10.1186/1756-3305-7-338.
181Non-CNA2013virologyArizona109Environ Health PerspectJournal Article24058050Morin CW, Comrie AC, Ernst K. Climate and dengue transmission: evidence and implications. Environ Health Perspect. 2013 Nov-Dec;121(11-12):1264-72. doi: 10.1289/ehp.1306556. Epub 2013 Sep 20.
182Non-CNA2011bloodNorth Carolina109PLoS Negl Trop DisJournal Article21713020de Alwis R, Beltramello M, Messer WB, Sukupolvi-Petty S, Wahala WM, Kraus A, Olivarez NP, Pham Q, Brien JD, Tsai WY, Wang WK, Halstead S, Kliks S, Diamond MS, Baric R, Lanzavecchia A, Sallusto F, de Silva AM. In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl Trop Dis. 2011 Jun;5(6):e1188. doi: 10.1371/journal.pntd.0001188. Epub 2011 Jun 21.
183CNA2013isolation & purificationSingapore109Antiviral ResHistorical Article24076358Lim SP, Wang QY, Noble CG, Chen YL, Dong H, Zou B, Yokokawa F, Nilar S, Smith P, Beer D, Lescar J, Shi PY. Ten years of dengue drug discovery: progress and prospects. Antiviral Res. 2013 Nov;100(2):500-19. doi: 10.1016/j.antiviral.2013.09.013. Epub 2013 Sep 27.
184Non-CNA2009virologyCalifornia108Am J Trop Med HygJournal Article19270292Balsitis SJ, Coloma J, Castro G, Alava A, Flores D, McKerrow JH, Beatty PR, Harris E. Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am J Trop Med Hyg. 2009 Mar;80(3):416-24.
185Non-CNA2007pathogenicitySwitzerland108Immunol Cell BiolJournal Article17130899Pang T, Cardosa MJ, Guzman MG. Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol. 2007 Jan;85(1):43-5. doi: 10.1038/sj.icb.7100008. Epub 2006 Nov 28
186Non-CNA2006culicidaeU.K108Trends ParasitolJournal Article16713358Hemingway J, Beaty BJ, Rowland M, Scott TW, Sharp BL. The Innovative Vector Control Consortium: improved control of mosquito-borne diseases. Trends Parasitol. 2006 Jul;22(7):308-12. doi: 10.1016/j.pt.2006.05.003. Epub 2006 May 18.
187Non-CNA2005physiologyFrance108J Biol ChemJournal Article15855154Lozach PY, Burleigh L, Staropoli I, Navarro-Sanchez E, Harriague J, Virelizier JL, Rey FA, Desprès P, Arenzana-Seisdedos F, Amara A. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J Biol Chem. 2005 Jun 24;280(25):23698-708. doi: 10.1074/jbc.M504337200. Epub 2005 Apr 26.
188Non-CNA2000isolation & purificationCuba108Am J EpidemiolJournal Article11085389Guzmán MG, Kouri G, Valdes L, Bravo J, Alvarez M, Vazques S, Delgado I, Halstead SB. Epidemiologic studies on Dengue in Santiago de Cuba, 1997. Am J Epidemiol. 2000 Nov 1;152(9):793-9; discussion 804. doi: 10.1093/aje/152.9.793.
189Non-CNA2015immunologyU.K108Nat Rev ImmunolJournal Article26603900Screaton G, Mongkolsapaya J, Yacoub S, Roberts C. New insights into the immunopathology and control of dengue virus infection. Nat Rev Immunol. 2015 Dec;15(12):745-59. doi: 10.1038/nri3916.
190Non-CNA2015aedesU.K108Sci DataDataset26175912Kraemer MU, Sinka ME, Duda KA, Mylne A, Shearer FM, Brady OJ, Messina JP, Barker CM, Moore CG, Carvalho RG, Coelho GE, Van Bortel W, Hendrickx G, Schaffner F, Wint GR, Elyazar IR, Teng HJ, Hay SI. The global compendium of Aedes aegypti and Ae. albopictus occurrence. Sci Data. 2015 Jul 7;2:150035. doi: 10.1038/sdata.2015.35. eCollection 2015.
191Non-CNA2012immunologyIndiana108J VirolJournal Article22238318Wrammert J, Onlamoon N, Akondy RS, Perng GC, Polsrila K, Chandele A, Kwissa M, Pulendran B, Wilson PC, Wittawatmongkol O, Yoksan S, Angkasekwinai N, Pattanapanyasat K, Chokephaibulkit K, Ahmed R. Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans. J Virol. 2012 Mar;86(6):2911-8. doi: 10.1128/JVI.06075-11. Epub 2012 Jan 11.
192Non-CNA2011metabolism108VirusesJournal Article22049308Smit JM, Moesker B, Rodenhuis-Zybert I, Wilschut J. Flavivirus cell entry and membrane fusion. Viruses. 2011 Feb;3(2):160-71. doi: 10.3390/v3020160. Epub 2011 Feb 22.
193Non-CNA2009climatePuerto Rico107PLoS MedJournal Article19918363Johansson MA, Cummings DA, Glass GE. Multiyear climate variability and dengue--El Niño southern oscillation, weather, and dengue incidence in Puerto Rico, Mexico, and Thailand: a longitudinal data analysis. PLoS Med. 2009 Nov;6(11):e1000168. doi: 10.1371/journal.pmed.1000168. Epub 2009 Nov 17
194Non-CNA2011prevention & controlFrance107VaccineJournal Article21745521Guy B, Barrere B, Malinowski C, Saville M, Teyssou R, Lang J. From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine. Vaccine. 2011 Sep 23;29(42):7229-41. doi: 10.1016/j.vaccine.2011.06.094. Epub 2011 Jul 13.
195CNA2006classificationNicaragua107Am J Trop Med HygJournal Article16525106Balmaseda A, Hammond SN, Pérez L, Tellez Y, Saborío SI, Mercado JC, Cuadra R, Rocha J, Pérez MA, Silva S, Rocha C, Harris E. Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg. 2006 Mar;74(3):449-56.
196CNA2016isolation & purification107MMWR Morb Mortal Wkly RepJournal Article27254248Rabe IB, Staples JE, Villanueva J, Hummel KB, Johnson JA, Rose L, Hills S, Wasley A, Fischer M, Powers AM. Interim Guidance for Interpretation of Zika Virus Antibody Test Results. MMWR Morb Mortal Wkly Rep. 2016 Jun 3;65(21):543-6. doi: 10.15585/mmwr.mm6521e1.
197Non-CNA2011transmissionTexas106Nat Rev MicrobiolJournal Article21666708Vasilakis N, Cardosa J, Hanley KA, Holmes EC, Weaver SC. Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health. Nat Rev Microbiol. 2011 Jun 13;9(7):532-41. doi: 10.1038/nrmicro2595.
198Non-CNA2014virologyU.K105PLoS Negl Trop DisJournal Article24810901Bowman LR, Runge-Ranzinger S, McCall PJ. Assessing the relationship between vector indices and dengue transmission: a systematic review of the evidence. PLoS Negl Trop Dis. 2014 May 8;8(5):e2848. doi: 10.1371/journal.pntd.0002848. eCollection 2014 May.
199Non-CNA2011epidemiologyMassachusetts105PLoS Negl Trop DisComment21647309Madoff LC, Fisman DN, Kass-Hout T. A new approach to monitoring dengue activity. PLoS Negl Trop Dis. 2011 May;5(5):e1215. doi: 10.1371/journal.pntd.0001215. Epub 2011 May 31.
200Non-CNA2011epidemiologyMassachusetts105PLoS Negl Trop DisEvaluation Study21647308Chan EH, Sahai V, Conrad C, Brownstein JS. Using web search query data to monitor dengue epidemics: a new model for neglected tropical disease surveillance. PLoS Negl Trop Dis. 2011 May;5(5):e1206. doi: 10.1371/journal.pntd.0001206. Epub 2011 May 31.
201CNA2010immunologyU.K105Proc Natl Acad Sci U S AJournal Article20837518Duangchinda T, Dejnirattisai W, Vasanawathana S, Limpitikul W, Tangthawornchaikul N, Malasit P, Mongkolsapaya J, Screaton G. Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16922-7. doi: 10.1073/pnas.1010867107. Epub 2010 Sep 13.
202CNA2005diagnosisJapan105J Clin MicrobiolEvaluation Study15956414Parida M, Horioke K, Ishida H, Dash PK, Saxena P, Jana AM, Islam MA, Inoue S, Hosaka N, Morita K. Rapid detection and differentiation of dengue virus serotypes by a real-time reverse transcription-loop-mediated isothermal amplification assay. J Clin Microbiol. 2005 Jun;43(6):2895-903. doi: 10.1128/JCM.43.6.2895-2903.2005.
203Non-CNA2010geneticsMissouri104J VirolJournal Article20592088Sukupolvi-Petty S, Austin SK, Engle M, Brien JD, Dowd KA, Williams KL, Johnson S, Rico-Hesse R, Harris E, Pierson TC, Fremont DH, Diamond MS. Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J Virol. 2010 Sep;84(18):9227-39. doi: 10.1128/JVI.01087-10. Epub 2010 Jun 30.
204CNA2010diagnosis104MMWR Morb Mortal Wkly RepCase Reports20489680. Locally acquired Dengue--Key West, Florida, 2009-2010. MMWR Morb Mortal Wkly Rep. 2010 May 21;59(19):577-81.
205CNA2008isolation & purificationBolivia104PLoS PathogCase Reports18421377Delgado S, Erickson BR, Agudo R, Blair PJ, Vallejo E, Albariño CG, Vargas J, Comer JA, Rollin PE, Ksiazek TG, Olson JG, Nichol ST. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog. 2008 Apr 18;4(4):e1000047. doi: 10.1371/journal.ppat.1000047.
206CNA2012epidemiologyFlorida104Emerg Infect DisJournal Article22257471Radke EG, Gregory CJ, Kintziger KW, Sauber-Schatz EK, Hunsperger EA, Gallagher GR, Barber JM, Biggerstaff BJ, Stanek DR, Tomashek KM, Blackmore CG. Dengue outbreak in Key West, Florida, USA, 2009. Emerg Infect Dis. 2012 Jan;18(1):135-7. doi: 10.3201/eid1801.110130.
207Non-CNA2007therapeutic useSingapore103J Infect DisJournal Article17262707Schul W, Liu W, Xu HY, Flamand M, Vasudevan SG. A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. J Infect Dis. 2007 Mar 1;195(5):665-74. doi: 10.1086/511310. Epub 2007 Jan 23.
208Non-CNA2006epidemiologyU.K103Proc Natl Acad Sci U S AJournal Article16966609Adams B, Holmes EC, Zhang C, Mammen MP Jr, Nimmannitya S, Kalayanarooj S, Boots M. Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14234-9. doi: 10.1073/pnas.0602768103. Epub 2006 Sep 11.
209Non-CNA1998immunologyGermany102J ImmunolJournal Article9834124Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol. 1998 Dec 1;161(11):6338-46.
210Non-CNA2015chemistrySingapore102Nat CommunJournal Article25698059Fibriansah G, Tan JL, Smith SA, de Alwis R, Ng TS, Kostyuchenko VA, Jadi RS, Kukkaro P, de Silva AM, Crowe JE, Lok SM. A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Nat Commun. 2015 Feb 20;6:6341. doi: 10.1038/ncomms7341.
211Non-CNA2013metabolism102BloodJournal Article24009231Hottz ED, Lopes JF, Freitas C, Valls-de-Souza R, Oliveira MF, Bozza MT, Da Poian AT, Weyrich AS, Zimmerman GA, Bozza FA, Bozza PT. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood. 2013 Nov 14;122(20):3405-14. doi: 10.1182/blood-2013-05-504449. Epub 2013 Sep 5
212CNA2005geneticsFrance102Nat GenetJournal Article15838506Sakuntabhai A, Turbpaiboon C, Casadémont I, Chuansumrit A, Lowhnoo T, Kajaste-Rudnitski A, Kalayanarooj SM, Tangnararatchakit K, Tangthawornchaikul N, Vasanawathana S, Chaiyaratana W, Yenchitsomanus PT, Suriyaphol P, Avirutnan P, Chokephaibulkit K, Matsuda F, Yoksan S, Jacob Y, Lathrop GM, Malasit P, Desprès P, Julier C. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet. 2005 May;37(5):507-13. doi: 10.1038/ng1550. Epub 2005 Apr 17.
213Non-CNA2008immunologyFrance101Trans R Soc Trop Med HygJournal Article183428982008
214Non-CNA2006pathogenicityHawaii101Novartis Found SympHistorical Article17319151Gubler DJ. Dengue/dengue haemorrhagic fever: history and current status. Novartis Found Symp. 2006;277:3-16; discussion 16-22, 71-3, 251-3. doi: 10.1002/0470058005.ch2.
215Non-CNA1999virologyPeru101LancetJournal Article10543670Watts DM, Porter KR, Putvatana P, Vasquez B, Calampa C, Hayes CG, Halstead SB. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet. 1999 Oct 23;354(9188):1431-4. doi: 10.1016/S0140-6736(99)04015-5.
216Non-CNA1990analysisCuba101Am J Trop Med HygJournal Article2316788Guzmán MG, Kouri GP, Bravo J, Soler M, Vazquez S, Morier L. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg. 1990 Feb;42(2):179-84. doi: 10.4269/ajtmh.1990.42.179.
217Non-CNA2013virologyVietnam101Proc Natl Acad Sci U S AJournal Article23674683Nguyet MN, Duong TH, Trung VT, Nguyen TH, Tran CN, Long VT, Dui le T, Nguyen HL, Farrar JJ, Holmes EC, Rabaa MA, Bryant JE, Nguyen TT, Nguyen HT, Nguyen LT, Pham MP, Nguyen HT, Luong TT, Wills B, Nguyen CV, Wolbers M, Simmons CP. Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes. Proc Natl Acad Sci U S A. 2013 May 28;110(22):9072-7. doi: 10.1073/pnas.1303395110. Epub 2013 May 14.
218CNA2004isolation & purificationCuba101Int J Infect DisJournal Article14732325Guzmán MG, Kourí G. Dengue diagnosis, advances and challenges. Int J Infect Dis. 2004 Mar;8(2):69-80. doi: 10.1016/j.ijid.2003.03.003.
219Non-CNA1990immunologyMassachusetts100J ImmunolJournal Article2139079Littaua R, Kurane I, Ennis FA. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol. 1990 Apr 15;144(8):3183-6.
220Non-CNA1983biosynthesis100Am J Trop Med HygJournal Article6824120Halstead SB, Rojanasuphot S, Sangkawibha N. Original antigenic sin in dengue. Am J Trop Med Hyg. 1983 Jan;32(1):154-6. doi: 10.4269/ajtmh.1983.32.154.
221Non-CNA2015microbiologyU.K100Sci Transl MedJournal Article25787763Ferguson NM, Kien DT, Clapham H, Aguas R, Trung VT, Chau TN, Popovici J, Ryan PA, O'Neill SL, McGraw EA, Long VT, Dui le T, Nguyen HL, Chau NV, Wills B, Simmons CP. Modeling the impact on virus transmission of Wolbachia-mediated blocking of dengue virus infection of Aedes aegypti. Sci Transl Med. 2015 Mar 18;7(279):279ra37. doi: 10.1126/scitranslmed.3010370.
222Non-CNA2012bloodNetherlands100J Clin VirolJournal Article22014848van de Weg CA, Koraka P, van Gorp EC, Mairuhu AT, Supriatna M, Soemantri A, van de Vijver DA, Osterhaus AD, Martina BE. Lipopolysaccharide levels are elevated in dengue virus infected patients and correlate with disease severity. J Clin Virol. 2012 Jan;53(1):38-42. doi: 10.1016/j.jcv.2011.09.028. Epub 2011 Oct 19
223CNA2015epidemiologyFrance100Euro SurveillJournal Article25955774Delisle E, Rousseau C, Broche B, Leparc-Goffart I, L'Ambert G, Cochet A, Prat C, Foulongne V, Ferre JB, Catelinois O, Flusin O, Tchernonog E, Moussion IE, Wiegandt A, Septfons A, Mendy A, Moyano MB, Laporte L, Maurel J, Jourdain F, Reynes J, Paty MC, Golliot F. Chikungunya outbreak in Montpellier, France, September to October 2014. Euro Surveill. 2015 Apr 30;20(17):21108. doi: 10.2807/1560-7917.es2015.20.17.21108.